Відео

Watch how, as part of our campaign to ‘Rethink Liver Cancer’, AMMF supporter Benjamin Carey worked with his MP Ben Macpherson, MSP for Edinburgh Northern and Leigh, to highlight health inequities facing people with cholangiocarcinoma, also called bile duct cancer, in Scotland. Cholangiocarcinoma is a primary liver cancer with one of the worst 5-year survival rates of any cancer and early diagno...

The University of Nottingham is a pioneering university that provides an exceptional research-led education, and an outstanding student experience. Our vision is to be a university without borders, where we embrace the opportunities presented by a changing world, and where ambitious people and a creative culture will enable us to change the world for the better.

AMMF’s Hybrid 2024 European Cholangiocarcinoma Conference

2024: Day 1: Andy Clay - My Journey with Cholangiocarcinoma

AMMF Nutrition for the CCA Patient

2024: Day 3: Prof Rocio IR Macias - Transport proteins key players in CCA diagnosis, prognosis and treatment

Day 3: Question time - 3

2024: Day 3: Isioma Egbuniwe - Ultra high-resolution mapping of spatial patterns of gene and protein expression in CCA

2024: Day 3: Question time - 4

2024: Day 3: Francesco Amato - The role of monocytes in modulating chemotherapy response

2024: Day 3: Prof Rocio IR Macias - ENS-CCA COST Action project - An Update

2024: Day 3: Prof Stephanie Roessler - Early steps of CCA development genetic and epigenetic alterations

2024: Day 3: Conference highlights and close

2024: Day 3: Question time - 1

Day 3: Question time - 2

Day 3: Michela Polidoro - Cholangiocarcinoma-on-chip a 3D liver tumour platform for personalised...

Day 3: Dr Tim Kendall - Patients and the public in the research agenda

Day 3: Veronica Porreca - Deciphering the impact of THBS1,THBS2 and PEDF in the intrahepatic CCA...

Day 3: Marc Quinn - Somatic BRCA1 2 mutations in peri-hilar cholangiocarcinoma

Day 3: Micol Damiani - Multiplexed detection of biomarkers for HCC CCA using a novel nanopore...

Day 3: Prof Sheela Jayaraman - CCA-UK - An Update

Day 2: Prof Chris Verslype - CCA in Belgium - An Overview

Day 2: Mr Kristoffer Lassen - CCA in Norway - An Overview

Day 2: Prof John Bridgewater - Trials Immunotherapy etc

Day 2: Co-chairs Welcome

Day 2: Question time - 3

Day 2: Helen Morement - Overview of cholangiocarcinoma and AMMF's Work

Day 2: Ilona Smith - Between survival and disaster

Day 2: Prof Watcharin Loilome - Combating Cholangiocarcinoma in Thailand and Great Mekong...